Fluocinolone Acetonide EP Impurity G is chemically 2-((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2-Fluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,5,6,6a,6b,7,8,8a,11a,12,12a,12b-tetradecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate. Fluocinolone Acetonide EP Impurity G is supplied with detailed characterization data compliant with regulatory guideline. Fluocinolone Acetonide EP Impurity G can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluocinolone.
关键字： 医药对照品;
祥根生物医药于2008年12月成立，是一家集药物研发、生产、销售的创新型医药高科技企业，荣获“国家高新技术企业”和“博士后实践创新基地”等称号。祥根生物医药拥有药物成分标准物质、关键中间体、原料药与药品进出口全产业链平台。祥根是众多全球知名标准品（Aozeal/USP/EP/LGC/Bachem/TLC/TRC/意大利试剂等）和原料药（INKE/Bachem/瑞迪/意迪那等）总代理和授权代理商，处于行业领先水平。
祥根生物医药拥有一个尊重人才、重视绩效、持续创新的平台。 研发团队由多名海外高层次人才领衔，研发人员50余人；获得相关发明专利30余项。祥根生物医药的企业责任是：回报员工、回报合作伙伴、回报社会；企业愿景是：提升药品质量，保护人类健康。